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AbstrACt
Objective Older patients with hip fractures who are 
undergoing surgery are at high risk of significant 
mortality and morbidity including postoperative delirium. 
It is unclear whether different types of anaesthesia 
may reduce the incidence of postoperative delirium. 
This systematic review will investigate the impact of 
anaesthetic technique on postoperative delirium. Other 
outcomes included mortality, length of stay, complications 
and functional outcomes.
Design Systematic review of randomised controlled trials 
and non-randomised controlled studies.
Data sources Bibliographic databases were searched 
from inception to June 2018. Web of Science and ZETOC 
databases were searched for conference proceedings. 
Reference lists of relevant articles were checked, and 
clinical trial registers were searched to identify ongoing 
trials.
Eligibility criteria Studies were eligible if general and 
regional anaesthesia were compared in patients (aged 
60 and over) undergoing hip fracture surgery, reporting 
primary outcome of postoperative delirium and secondary 
outcomes of mortality, length of hospital stay, adverse 
events, functional outcomes, discharge location and quality 
of life. Exclusion criteria were anaesthetic technique or 
drug not considered current standard practice; patients 
undergoing hip fracture surgery alongside other surgery 
and uncontrolled studies.
results One hundred and four studies were included. 
There was no evidence to suggest that anaesthesia 
type influences postoperative delirium or mortality. 
Some studies suggested a small reduction in length of 
hospital stay with regional anaesthesia. There was some 
evidence to suggest that respiratory complications and 
intraoperative hypotension were more common with 
general anaesthesia. Heterogeneity precluded meta-
analysis. All findings were described narratively and 
data were presented where possible in forest plots for 
illustrative purposes.
Conclusions While there was no evidence to suggest 
that anaesthesia types influence postoperative delirium, 
the evidence base is lacking. There is a need to 
ascertain the impact of type of anaesthesia on outcomes 
with an adequately powered, methodologically rigorous 
study.
PrOsPErO registration number CRD42015020166.
IntrODuCtIOn  
There are an estimated 70 000–75 000 hip 
fractures in the UK each year with an annual 
cost of £2 billion.1 This is projected to rise 
and reach 100 000 patients a year and costing 
£3.6–5.6 billion by 2033.2 
Patients undergoing hip fracture surgery 
are often frail with intercurrent illness3 
and are at risk of mortality and significant 
morbidity. In 2014, the National Hip Frac-
ture Database reported 30-day mortality as 
7.5%.4 Following surgery, adverse outcomes 
can include delirium, myocardial infarction, 
pneumonia and cerebrovascular accident.5
Delirium is a common neuropsychiatric 
syndrome defined in the Diagnostic and 
Statistical Manual of Mental Disorders, 5th 
edition (DSM-V) as the disturbance of atten-
tion, awareness and cognition which develops 
over a short period of time, represents a 
change from baseline and tends to fluctuate 
during the course of the day.6 7 Postoperative 
delirium has been reported to affect between 
32% and 53.3% of patients and is associated 
with prolonged hospital stay, discharge to 
care homes, difficulty in regaining function 
in activities of daily living and increased risk 
of development of cognitive dysfunction and 
strengths and limitations of this study
 ► This systematic review provides an update to evi-
dence that examines whether the type of anaes-
thesia affects the development of postoperative 
delirium in patients with hip fractures.
 ► The review included randomised and non-ran-
domised studies that included one or more types of 
regional versus one or more types of general anaes-
thesia provided they are in current use as described 
in the UK.
 ► Other outcomes were mortality, length of hospital 
stay, adverse events, functional outcomes, dis-
charge location and quality of life.
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dementia in the future.8–13 The aetiology of delirium is 
multifactorial, with both modifiable and non-modifi-
able risk factors.14 15 There is no known treatment for 
delirium; however, a careful approach in the periopera-
tive period may reduce its incidence and severity.6 9 15–18 
Guideline committees have cautiously recommended 
that regional anaesthesia should be given unless contra-
indicated.1 9 19 Despite this, the type of anaesthesia admin-
istered in patients with hip fractures remains varied.4
Ninety-eight per cent of patients with hip fracture are 
offered surgery and will require anaesthesia.5 Anaesthesia 
can be broadly classified into general (GA) or regional 
anaesthesia (RA). RA uses neuraxial blocks that avoid the 
use of GA drugs and opiates which have been linked to 
postoperative delirium.3 Excessive depth of anaesthesia 
and perioperative hypotension have been reported in GA 
patients and are both associated with an increased risk 
of mortality.20 However, the risk of perioperative hypo-
tension and sedation is not completely eradicated with 
RA.21 22
Findings from previous systematic reviews looking at the 
effects of type of anaesthesia on postoperative outcomes 
in patients with hip fracture are broadly suggestive of 
improved outcomes3 5 23 24 and reduced incidence of post-
operative delirium in patients having RA.3 5 22 25 26 However, 
some studies included in these reviews reported use of 
outdated anaesthetic drugs that are no longer relevant 
to current clinical practice.5 24 Further limitations were 
the inclusion of only randomised controlled trials,3 5 23 24 
lack of focus on delirium as a primary outcome,3 5 22 24 26 a 
limited search strategy22 and restrictive selection criteria 
(eg, exclusion of studies with patients with cognitive 
impairment).23 25 26 Inadequate exploration of heteroge-
neity relating to delirium assessment and rating scales and 
assessment time points was also common. This systematic 
review aims to provide an up-to-date, comprehensive and 
methodologically robust analysis to examine the effect 
of RA versus GA on postoperative delirium and other 
outcomes in older patients undergoing surgery for hip 
fracture.
MEthODs
The protocol for this systematic review has been published 
and is registered with PROSPERO (CRD42015020166).27 
A summary of the methods is outlined below. Reporting 
of the systematic review was in accordance with the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses guidelines.28
search strategy and selection criteria
Bibliographic databases (Embase, MEDLINE, CINAHL 
and the Cochrane Library (CENTRAL)) were searched 
from inception to June 2018 using a combination of 
index terms and keywords relating to the population, 
intervention and comparator (see online supplemen-
tary appendix A for sample search strategy). There was 
no restriction by search date, study design or language. 
Web of Science and ZETOC databases were searched 
for conference proceedings. Reference lists of rele-
vant articles were checked, and clinical trial registers ( 
www. clinicaltrials. gov, www. isrctn. com and http://www. 
who. int/ ictrp/ en/) were searched to identify ongoing 
trials (online supplementary appendix B). Endnote V.7 
(Thomson Reuters) was used to store records and facili-
tate screening.
study selection
Studies were eligible for inclusion if they met the following 
predefined criteria:
1. Population—patients aged ≥60 years (or with a major-
ity ≥60) undergoing surgery for fragility hip fracture.
2. Intervention and comparator—one or more types of 
regional versus one or more types of general anaesthe-
sia provided they are in current use as described in the 
UK.19
3. Outcomes—primary outcome: postoperative delirium 
(any criteria as defined by study authors); secondary 
outcomes: mortality, length of hospital stay, adverse 
events, functional outcomes, discharge location and 
quality of life.
4. Randomised or non-randomised controlled studies 
(prospective or retrospective).
Exclusion criteria for the primary outcome of ‘post-
operative delirium’ were anaesthetic technique or drug 
not considered current standard practice (eg, outdated 
anaesthetic agents—halothane, enflurane, xenon); 
patients undergoing hip fracture surgery alongside other 
surgery (eg, multiple trauma injuries); uncontrolled 
studies. Two reviewers (RC, VP) independently screened 
titles and abstracts. Any disagreements were resolved with 
the support of JY. Reasons for exclusion were recorded at 
the full text stage.
Data extraction and quality assessment
A piloted, standardised data extraction form was used 
to record information on study design, patient charac-
teristics, type of surgery, anaesthesia type and outcomes. 
The Cochrane Collaboration risk of bias tool29 was used 
to assess the methodological quality of randomised 
controlled trials and the Newcastle–Ottawa scale30 for 
non-randomised studies. Full translations could not be 
obtained for three included studies31–33; extracted data 
are therefore based mainly on numerical data and the 
English abstract. Data was extracted by RC and VP, with 
data checking by JY (for RC) and JD (for VP).
Data analysis and synthesis
Findings were grouped according to outcome. Where 
there was sufficient data, results were presented in forest 
plots (delirium, mortality and length of hospital stay). 
Results for studies not included in the forest plot were 
reported narratively. Effect estimates were not pooled as 
clinical and methodological heterogeneity was considered 
to be too great. Forest plots were thus used for illustra-
tive purposes only and potential sources of heterogeneity 
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(such as study design or timing of assessment) have been 
highlighted. Where studies did not report sufficient 
data for inclusion into a forest plot (eg, results reported 
narratively only, or a p value only stated) results or 
conclusions from the study were nonetheless described 
in order to report the totality of the available evidence. 
Occurrence of delirium and mortality were reported as 
relative risks or ORs; length of stay (days) was reported 
as a mean difference. Adverse events were tabulated, 
where possible, according to the postoperative morbidity 
survey (POMS) criteria.34 Findings for other outcomes 
(functional outcomes, quality of life and discharge loca-
tion) were reported narratively as heterogeneity and/or 
a paucity of data precluded representation in forest plots. 
Formal sensitivity analysis according to study quality, and 
assessment of publication bias using funnel plots were not 
possible.
Patient and public involvement
This systematic review is part of a programme of research 
looking at impact of anaesthesia on postoperative 
delirium. The research programme has received input 
from patient partner and Clinical Research Ambassador 
Group at Heart of England National Health Service Foun-
dation Trust.
rEsults
Of 4859 citations screened, 104 studies met the eligibility 
criteria (figure 1). There were 7 randomised controlled 
trials (RCTs), 34 prospective and 63 retrospective 
controlled studies.
Twenty-two studies reported delirium (5 RCTs,35–39  
9 prospective18 40–47 and 8 retrospective studies48–55); 58 
studies reported mortality (2 RCTs,35 38 12 prospective42 45 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram. The PRISMA diagram 
details our search and selection process applied during the review.
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56–65 and 44 retrospective studies4 20 21 31 32 48 51 52 54 66–100); 
25 studies reported length of hospital stay (2 RCTs,36 38 6 
prospective42 45 58 101–103 and 17 retrospective studies21 51 57 
68 70 71 75 78 80–83 95 98 99 104 105); 27 studies reported adverse 
events (4 RCTs,35 36 39 106 7 prospective42 43 45 58 101 107 108 and 
16 retrospective studies20 21 48 51 52 68 69 71 75 79–81 95 96 109 110); 
11 studies reported functional outcome (3 RCTs,35 36 111 4 
prospective42 45 103 112 and 4 retrospective studies62 73 105 113); 
5 studies reported discharge location (2 prospective43 114 
and 3 retrospective studies21 48 99).
Thirteen potentially relevant ongoing trials were iden-
tified, with three (ISRCTN15165914, NCT03318133 and 
NCT02213380) planning to measure delirium postoper-
atively (online supplementary appendix B). No interim 
data were available.
study, population and intervention characteristics
Given the large number of studies identified, only the 22 
studies reporting the primary outcome of postoperative 
delirium have been described in detail (table 1).
Primary outcome
Postoperative delirium
Fifteen studies (four RCTs,36–39 six prospective studies18 41–45 
and five retrospective studies22 48 51 52 54) reporting unad-
justed results are represented in the forest plot (figure 2). 
Of these 15 studies, only one study found a statistically 
significant benefit in favour of general anaesthesia52 
and overall there was no evidence of a benefit of one 
type of anaesthesia over another. Seven studies were not 
included in forest plot due to insufficient data with five 
studies40 46 47 50 53 reported only as abstract, one RCT35 did 
not report delirium as dichotomous outcome and one 
retrospective study55 only included patients who devel-
oped delirium post surgery. Only two studies compared 
delirium according to anaesthetic types. One retrospec-
tive study that only included patients with delirium found 
GA to be a significant risk factor for immediate delirium 
(within 24 hours of surgery) compared with RA, but GA 
was not associated with delayed delirium (after 24 hours 
post surgery).55 A further study reported as abstract also 
found that delirium was more common with GA, but this 
did not remain statistically significant on multivariable 
analysis. The assessment tool for delirium was not stated.47
Overall, there was substantial heterogeneity across 
the 22 studies regarding assessment tools, assessment 
time-points and anaesthetic protocol. Many assessment 
tools were poorly defined. Only 7 out of 22 studies used 
either DSM-IV criteria18 40 49 53 54 or Abbreviated Mental 
Test.35 50 Delirium or cognitive impairment was frequently 
not a primary outcome, but listed as one of several 
complications.
None of the RCTs that were quality assessed reported 
all relevant details (table 2A). Details were lacking on the 
delirium assessment tools used38 and method of randomi-
sation.35 36 38 39 Blinding of outcome assessment was either 
not undertaken38 or unclear.36 There appeared to be no 
loss to follow-up in three RCTs,36 38 39 but this was unclear 
for the other RCT.35 The RCT by Kamitani et al was not 
quality assessed as a full translation was not available.37
The observational studies were generally considered 
to be at low risk of bias in terms of patient eligibility; 
however, most had no details on blinding of outcome 
assessors and the level of completeness of data (table 2B). 
There was variation in reporting and adjustment of 
potential confounding factors such as the American 
Society of Anesthesiologists Physical Status Classification 
System (ASA) score, age, gender, comorbidities, surgery 
type, time to surgery and physical function. There were 
no details on characteristics of patients who completed 
follow-up compared with those lost to follow-up. There 
was also a general lack of detail on the type of assessment 
tool used and/or where the cut-off for a ‘positive’ diag-
nosis of delirium was.
secondary outcomes
Mortality
Two RCTs reported mortality (table 3). One found a small 
and statistically significant survival benefit at 120 days and 
1 year for GA, but no such benefit was evident at 30 or 
90 days of follow-up.38 Ten observational studies reported 
adjusted results or results based on a matched analysis 
(table 3). Two of these20 68 found a statistically signifi-
cant benefit in favour of RA for in-hospital mortality. The 
remaining eight studies found no significant differences. 
There was a lack of consistency across studies in terms of 
number and type of variables included in models.
Of the remaining 46 studies (results not shown) 
reporting unadjusted mortality results only, six56 60 67 73 74 76 
found statistically significant results in favour of RA. The 
remainder found no statistically significant differences or 
benefit comparing RA with GA.
Overall, there is a paucity of good-quality evidence 
evaluating mortality, with only one good-quality RCT38 
suggesting benefit from GA at later but not earlier 
time-points.
length of hospital stay
Twenty-five21 36 38 42 45 51 57 58 68 70 71 75 78 80–83 95 98 99 101–105 
studies reported length of hospital stay; nine could be 
included in a forest plot (figure 3). There was no differ-
ence in length of hospital stay based on one RCT.38 Three 
retrospective studies21 68 81 compared patients with propen-
sity score matching and showed a slight benefit towards a 
shorter length of stay with RA; while this was statistically 
significant in two studies,21 68 the absolute reduction was 
small (up to around a third of a day). Results from the 
studies reporting unadjusted results were inconsistent, 
with three finding no difference71 75 80 and two finding a 
benefit from RA.82 101
Data were not available from the remaining 16 studies 
due to lack of data (three studies57 70 98 were abstracts 
only, six studies36 42 78 99 104 105 did not provide raw data, two 
studies45 95 did not link data with types of anaesthesia and 
five studies51 58 83 102 103 only provided median length of 
stay). The RCT36 and the five prospective studies42 45 58 102 103 
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did not show any significant differences. Results from 
the 10 retrospective studies were also inconsistent: three 
studies57 70 83 reported no difference, four studies51 78 99 104 
found a statistically significant benefit for and one study95 
reported a statistically significant benefit for GA. Fukuda 
et al reported a statistically significant effect in favour of 
spinal anaesthesia, but this effect was lost after propen-
sity score matching.105 One large study (Nishi, n=16 687) 
reported in abstract form only reported a slightly shorter 
length of stay with RA; it was unclear if this was statistically 
significant.98
Most studies reported mean length of stay, but some 
also reported the median, which may be more appro-
priate. Of 12 studies21 36 45 51 57 70 71 83 95 99 102 103 reporting 
the median, nine studies21 36 45 57 70 71 83 102 103 found no 
statistically significant differences. Three studies found 
a statistically significant difference in medians, two of 
which favoured RA51 99 and one favoured GA.95
Adverse events
Twenty-seven studies reported adverse events (table 4). 
There were many gaps in reporting of POMS adverse 
events, and it is uncertain whether this reflects non-oc-
currence or non-reporting of such events. Most 
commonly reported adverse events were pulmonary 
(10 studies)20 21 35 45 48 49 62 69 89 91 and cardiovascular 
events (9 studies).21 35 39 48 58 68 69 81 95 For pulmonary 
events, six studies found no statistically significant differ-
ences.35 45 49 69 89 91 Four studies found a statistically signifi-
cant difference in favour of RA (fewer cases of ventilatory 
support,68 respiratory failure20 68 and ‘overall pulmo-
nary’ adverse events20 51). There were no differences in 
occurrences of pneumonia35 48 52 95 or hypoxia.75 101 The 
most commonly reported cardiovascular adverse events 
were myocardial infarction39 48 68 95 and thromboembolic 
events.35 58 69 81 95 No differences were found for myocar-
dial infarction.39 48 52 68 75 95 Three studies69 81 95 reported 
higher incidence of thromboembolic events in GA group.
Nine studies summarised overall adverse events with 
the majority finding no differences between the types of 
anaesthesia. Where there was a significant difference, this 
was in favour in RA (eg, fewer incidences of ‘all compli-
cations’,51 69 intensive treatment unit (ITU) admissions,68 
stroke68 or requirement for blood transfusion). Three 
studies106 108 109 found higher incidences of hypotension 
in the GA group.
The results are thus suggestive of a lower incidence 
of postoperative respiratory, cardiac and overall compli-
cations in the RA group. However, reporting of adverse 
events, including methods of ascertainment, was inconsis-
tent and limited.
Functional outcomes
Eleven studies reported functional outcomes using a 
variety of outcome measures. Two RCTs reported a signifi-
cantly quicker time to ambulation in the RA group (3.3 
days RA vs 5.5 days GA)35 and a statistically significant 
earlier discharge time from PACU (post-anaesthesia care A
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unit) in the RA group (RA 15 (5–30) min vs GA 55 (15–80) 
min, p=0.0005).36 However, one RCT found that patients 
given RA were slower to be discharged from PACU (mean 
time to discharge GA 35.04 min (SD 3.39) vs RA 41.26 min 
(SD 8.37), p=0.001).111 No significant differences were 
found in the non-randomised studies regarding time to 
ambulation,103 112 113 walking speed,62 time to rise from 
chair,42 mean Barthel’s score73 or ambulation at 3, 6 and 
12 months post surgery.45 105 Overall results may suggest 
a small benefit from RA for immediate post-anaesthetic 
mobilisation. However, the evidence is limited by small 
sample size, unknown method of outcome assessment 
and blinding of assessors.
Discharge location
Five non-randomised studies described discharge loca-
tions of patients following hip fracture.21 43 48 99 114 One 
study with only 14 patients reported that more patients 
returned home in the RA group.45 A large retrospective 
study reported lower odds of returning to home resi-
dence and higher chance of admitting to healthcare 
facility in GA group compared with RA (16 695 patients, 
return home adjusted OR 0.91 (95% CI 0.84 to 0.97); 
healthcare facility admission OR 1.10 (95% CI 1.03 to 
1.19).99 A cohort study of 4815 patients found operation 
under GA significantly increased risks of rehabilitation 
admission instead of home (adjusted OR 1.74, 95% CI 
1.34 to 2.25, p<0.001).114 However, two larger studies21 109 
found no difference in discharge location between GA or 
RA groups.
Quality of life
There were no studies that evaluated the effect of type of 
anaesthesia on quality of life in patients after hip fracture 
surgery.
DIsCussIOn
For the primary outcome of postoperative delirium, this 
systematic review did not find any difference between 
types of anaesthesia. Furthermore, no survival benefit 
could be demonstrated with either type of anaesthesia 
up to 1 year postoperatively. A small number of studies 
suggested that fewer adverse events might be associated 
with RA. Similarly, some studies were suggestive of a small 
reduction in hospital stay with RA. Data were limited for 
functional outcomes and discharge data. Two small RCTs 
suggested a benefit from RA for immediate post-anaes-
thetic mobilisation. There were no studies that reported 
on quality of life after different types of anaesthesia.
This is the most comprehensive and methodologically 
robust systematic review to date. It includes both RCTs 
Figure 2 Forest plot of studies reporting the unadjusted relative risk of postoperative delirium with GA compared with spinal 
anaesthesia. Some studies are represented more than once to show results for different definitions of delirium or for different 
assessment time-points. CAM, confusion assessment method; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 
4th edition; MFIP, Multi-factorial Intervention Program; MMSE, Mini–Mental State Examination; RR, relative risk; SC, standard 
care; UCD, unspecified cognitive dysfunction. 
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and non-randomised controlled studies, focusing on 
delirium as a primary outcome as well as synthesising find-
ings for a range of other important outcomes including 
adverse events. Results for RCTs, non-randomised studies, 
adjusted and unadjusted results were presented and 
considered separately. It was anticipated that non-ran-
domised studies, which are more prone to bias, may over-
estimate effect sizes compared with RCTs. No such trends 
were observed, however, as studies of any design mostly 
showed no difference in effect.
A sensitive search strategy means it is unlikely that many 
studies would have been missed. Careful consideration 
of heterogeneity has meant that no meta-analyses were 
undertaken, but results were presented in forest plots 
where possible to show the overall direction of effect and 
heterogeneity between studies.
Delirium can be diagnosed using the criteria from the 
DSM-V or WHO’s ICD-10 classification of diseases.7 115 
However, in clinical practice, the criteria can be difficult to 
apply116 and tools such as the confusion assessment method, 
Delirium Rating Scale revised-98, Neelon and Champagne 
Confusion Scale117 or 4 ‘A’s’ Test have been advocated as 
validated screening tools.6 116 118 No consensus exists in the 
literature as to which tool should be the gold standard.6 119 120 
The accurate assessment of delirium can be affected by the 
presence of pain and residual drugs in the immediate period 
following surgery; therefore, timing of assessment is also 
important.121 No significant differences were found for the 
incidence of postoperative delirium, based on 4 RCTs and 
14 non-randomised studies, but there were significant differ-
ences in the assessment tools and the assessment time-points. 
Most of the RCTs were small and most likely underpowered. 
In the largest RCT,38 delirium was not a primary outcome 
and the assessment tool used or the timing of assessments 
was not reported. The pathophysiology of delirium remains 
poorly understood, but there are a combination of pre-ex-
isting and precipitating factors that can predispose the 
patient to postoperative delirium.11 122 123 Pre-existing patient 
risk factors including age >70 years, pre-existing cognitive 
impairment, history of postoperative delirium, visual impair-
ment, cerebrovascular disease and renal impairment124 125 
are associated with higher risk of delirium. Precipitating 
factors can include acute injury such as a hip fracture, 
malnutrition, electrolyte imbalance and the use of urinary 
catheter and physical restraints.125 Specific perioperative 
risk factors include intraoperative blood loss, postoperative 
transfusions and severe acute pain.126 127 The studies that 
adjusted for confounders and reported delirium40 42 52 53 
found no association between type of anaesthesia and post-
operative delirium. Confounders adjusted for included 
demographics, ASA classification, comorbidities, nutritional 
status, fracture type, preoperative blood transfusion and 
readmission.42 52 53 However, with multifactorial risk factors 
for delirium, it is difficult to encompass all variables. Other 
important characteristics such as anaemia, time to surgery, 
blood loss, intraoperative  hypotension and sedation can 
also influence outcome but were less frequently included 
as variables. Given the lack of consistency across studies in S
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terms of number and type of variables included in models 
and the reporting of these, it is not possible to gauge the 
overall impact that adjusting for confounders may have on 
the direction of effect.
There were limitations in the primary data included in 
this systematic review. There were a limited number of RCTs 
(3% of total number of patients included for the primary 
outcome) and many of the non-randomised studies did 
not make any attempts to adjust for potential confounding 
factors. When confounding variables were considered, this 
was often done for mortality only. There was significant 
heterogeneity across studies in study design, population 
age, comparators, assessment time-points and definition of 
outcomes (particularly delirium) that precluded quantita-
tive pooling.
Detailed reporting of anaesthetic techniques was subop-
timal especially for GA techniques. RA techniques employed 
were more commonly reported, but the specific drugs used 
were not described. Opioids are known to cause delirium3 128 
and acute pain is a well-recognised precipitating factor of 
delirium, but both were poorly reported. While most studies 
planned to collect adverse events data, it was unclear 
whether adverse events were predetermined. Small sample 
sizes (n<30) and rare occurrences of adverse events mean 
that many studies were likely underpowered.35 36 48 101 The 
style of data reporting in included studies could also lead 
to over-reporting of complications; for example, a patient 
could develop pneumonia, which led to respiratory failure 
and the need for inotropic and ventilatory support and ITU 
admission. Thus, five adverse events would be attributable to 
a single patient, but this may not be evident from the data. 
Incidence of intraoperative hypotension was not captured by 
POM categories, as inotropic support use was not reported. 
Hypotension can lead to hypoperfusion and organ damage. 
A recent analysis of data from an audit of outcomes in 
patients with hip fracture demonstrated increased risk of 
death associated with intraoperative hypotension. In our 
review, three studies106 108 109 examined hypotension, all of 
which found higher incidences of hypotension in the GA 
group. Four studies52 69 106 109 also found significantly higher 
volumes of fluids and blood products transfused in the GA 
group.
Subgroup analysis was not feasible and no individual 
studies reported findings for different subgroups. It is 
possible that there are some patients who may, in some 
circumstances, benefit from RA compared with GA that have 
not been captured by the evidence presented in this system-
atic review. Subgroup analysis of specific at-risk patients, for 
example the frail and the very elderly, may suggest a benefit 
for either regional or general anaesthesia in certain popula-
tion groups. 
Older patients are at high risk of adverse outcomes post-
operatively due to age-related physiological decline, multiple 
comorbidities and polypharmacy.129 Principles of care for 
older patients in the perioperative setting should employ an 
anaesthetic technique that leads to rapid recovery, dosing of 
drugs specific to individual pharmacokinetic variation and 
appropriate pain management strategies.130 Most recently, 
Figure 3 Forest plot of studies reporting length of hospital stay. Weighted mean difference in number of days between GA and 
RA (GA minus RA). WMD >0 means longer stay for GA and favours RA. WMD <0 means longer stay for RA and favours GA. GA, 
general anaesthesia; RA, regional anaesthesia; RCT, randomised controlled trial; WMD, weighted mean difference.
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Table 4 Summary findings table of studies reporting adverse events
POMS categories Study Adverse event description GA RA Summary statistic*/p value
Pulmonary Basques et al 201595 Ventilatory support 58/7253 (0.8%) 13/2589 (0.5%) NR
Pneumonia 261/7253 (3.6%) 108/2589 (4.2%) NR
Bigler et al 198535 Pneumonia 2/20 1/20 NR
Chu et al 201568 Respiratory failure 868/52 043
(1.61%)
328/52 044 (0.63%) OR 2.71 (95% CI 2.38 to 3.01), 
p<0.001
Favours RA
Ventilatory support 4008/52 043 (7.70%) 338/52 044 (1.44%) OR 6.08 (95% CI 5.59 to 6.61), 
p<0.001
Favours RA
Konttinen and 
Rosenberg 200648
Pneumonia 0/3 2/11 NR
Liu et al 201475 Overall pulmonary 18/172 (25%) 27/145 (25.5%) p=0.934 NS
Hypoxia 19/72 (26.4%) 23/145 (15.9%) p=0.065 NS
Le-Wendling et al  
201221
Overall pulmonary 17/235 (6%) 1/73 (1%) OR 2.2 (95% CI 0.7 to 
7.2) p=0.0841
Favours RA
Naja et al 2000101 Hypoxia 2/30 (6%) 0/30 (0%) NR
Neuman et al 201220 Overall pulmonary 1030/12 904 (8.1%) 359/5254 (6.8%) p=0.005
Favours RA
Respiratory failure 1040/12 904 (5%) 178/5254 (3.4%) p<0.0001
Favours RA
O’Hara et al 200052 Pneumonia 174/6206 (2.8%) 84/3219 (2.6%) OR 1.21 (95% CI 0.87 to 1.68)
NS
Shih et al 201051 Overall pulmonary 11/167 (6.6%) 3/168 (1.8%) p<0.03
Favours RA
Cardiovascular Basques et al 201595 Myocardial infarction 137/7253 (1.9%) 49/2859 (1.9%) NR
Thromboembolic 138/7253 (1.9%) 25/2589 (1.0%) NR
Bigler et al 198535 Cardiovascular decompensation 1/20 1/20 NR
Pulmonary embolism 1/20 1/20 NR
Chu et al 201568 Myocardial infarction 188/52 043 (0.36%) 169/52  044 (0.32%) OR 1.11 (95% CI 0.9 to 1.37), 
p=0.31 NS
Fields et al 201569 Thromboembolism 1.64% 0.72% p=0.004
Favours RA
Konttinen and 
Rosenberg 200648
Myocardial infarction 0/3 1/11 NR
Neuman et al 201639 Myocardial infarction 1/6 0/6 NR
Le-Wendling et al  
201221
All cardiovascular complications NR NR OR 1.7 (95% CI 0.4 to 6.3) NS
Seitz et al 201481 Deep vein thrombosis 47/8818 (0.5%) 41/12 155 (0.3%) p=0.03
NS when matched
Pulmonary embolism 100/8818 (1.1%) 93/12 155 (0.8%) p=0.006
NS when matched
Sutcliffe and Parker 
199458
Deep vein thrombosis 16/950 (1.7%) 14/383 (3.7%) p<0.05 NS
Pulmonary embolism NR NR NS
Infectious Bigler et al 198535 Wound infection 1/20 0/20 NR
Fields et al 201569 Urinary tract infection 5.76% 8.87% p<0.0001
Favours GA
Rashid et al 201380 Urinary tract infection NR NR NS
Basques et al 201595 Wound infection 94/7253 (1.3%) 39/2589 (1.5%) NS
Renal Basques et al 201595 Acute renal failure 29/7253 (0.4%) 10/2589 (0.4%) NS
Bigler et al 198535 Urinary retention 4/20 5/20 NS
Chu et al 201568 Acute renal failure 78/52 043 (0.15%) 56/52  044 (0.11%) p=0.06 NS
Naja et al 2000101 Acute renal failure 2/30 (6%) 0/30 (0%) NS
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POMS categories Study Adverse event description GA RA Summary statistic*/p value
Overall complications Gilbert et al 200042 Serious medical complications 55/311 (17.7%) 79/430 (18.4%) OR 0.92 (95% CI 0.61 to 1.4) NS
Gilbert et al 200042
Whiting et al 201596
Fewer medical complications 109/311 (35.1%) 151/430 (35.1%) OR 1.28 (95% CI 0.90 to 1.82) 
NS
Surgical complications 15/311 (4.8%) 19/430 (4.4%) OR 1.08 (95% CI 0.65 to 1.21) 
NS
Major complications NR NR OR 1.43 (95% CI 1.16 to 1.77) 
NS
Whiting et al 201596
Fields et al 201569
Minor complications NR NR OR 1.02 (95% CI 0.82 to 1.26) 
NS
All complications NR NR OR 1.24 (95% CI 1.05 to 1.48) 
NS
All complications 2357/4813 (48.97%) 830/1815 (45.75%) OR 1.29 (95% CI 1.13 to 1.47), 
p=0.0002
Favours RA
Hekimoglu 
Sahin et al 201271
All complications NR NR NS
Ilango et al 201543 All complications NR NR NS
Koval et al 199945 All complications 41/362 (11.3%) 32/280 (11.4%) NS
Liu et al 201475 All complications 17/72 (23.6%) 50/145 (34.5%) p=0.165 NS
Le-Wendling et al  
201221
All complications NR NR OR 1.7 (95% CI 0.7 to 4.1) NS
Rashid et al 201380 All complications 22% 19% Log regression model p=0.002
Favours RA
Shih et al 201051 All complications 21/167 (12.6%) 9/168 (5.4%) p<0.02
Favours RA
Chu et al 201568 ITU admissions 5743/52 043 (11.03%) 3205/52 044 (6.16%) OR 1.95 (95% CI 1.87 to 2.05), 
p<0.001
Favours RA
Specific complications Chu et al 201568 ITU stay >3 days 1206/52 043 (2.32%) 411/52 044 (0.79%) p<0.001
Favours RA
Baumgarten et al  
2012107
Pressure ulcers 10/328 (3.0%) 18/313 (5.8%) OR 1.3 (95% CI 1.0 to 1.6) 
Favours GA
Casati et al 200336 Hypotension requiring crystalloid 
infusion
12/15 (80%) 7/15 (46%) p=0.05 NS
Maia et al 2014108 Intraoperative hypotension 25/50 80/173 p=0.014
Favours RA
Minville et al 2008109 Intraoperative hypotension 35/42 (83%) 74/109 (68%) NS
Gadsden 2016110 Intraoperative hypotension 569/745 1144/1528 Favours RA
p<0.0001
Messina et al 2013106 Haemodynamic changes first 
10 min
Mean arterial blood pressure, heart rate, 
systemic vascular resistance index changes. 
More disturbance in GA
Favours RA
Basques et al 201595 Blood transfusion 2843/7253 (39.2%) 851/2589 (32.9%) Matched OR 1.34 (95% CI 1.22 
to 1.49), p<0.001
Favours RA
Fields et al 201569 Blood transfusion 45.49% 39.34% p<0.0001
Favours RA
Minville et al 2008109 Blood transfusion 23% 4% p<0.05
Favours RA
Shih et al 201051 Blood loss Median 250 (0–
1600) mL
Median 200 (0–
1200) mL
p=0.01
Favours RA
Chu et al 201568 Stroke 840/52 043 (1.61%) 717/52 044 (1.38%) OR 1.18 (95% CI 1.07 to 1.31), 
p=0.001
Favours RA
Liu et al 201475 Stroke 5/72 (5.9%) 4/145 (2.8%) p=0.145 NS
*OR, GA vs RA.
GA, general anaesthesia; ITU, intensive treatment unit; NR, not reported; NS, not significant; POMS, postoperative morbidity survey; RA, regional anaesthesia. 
Table 4 Continued 
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the European Society of Anaesthesiology consensus guide-
line on postoperative delirium also did not find substantial 
evidence to recommend a specific type of anaesthetic tech-
nique but advocates intraoperative monitoring to avoid 
swings in blood pressure and excessive depth of anaes-
thesia.131 Given the lack of standardised assessment tools 
of delirium and the paucity of suitably powered, method-
ologically sound studies, uncertainty remains regarding any 
potential benefits of certain types of anaesthesia. However, 
even a modest reduction in adverse events and length of 
hospital stay could benefit many patients and result in cost 
savings for healthcare providers. Future research examining 
postoperative delirium should include robust assessment 
and diagnosis of delirium. There is also an urgent need for 
high-quality research comparing anaesthetic techniques that 
focus on patient-related outcomes such as quality of life and 
functional outcomes.
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